Breakthroughs in treating NSCLC: Targeting KRAS скачать в хорошем качестве

Breakthroughs in treating NSCLC: Targeting KRAS

🔬 Advances in NSCLC treatment: spotlight on KRAS mutations KRAS-mutant NSCLC is at the forefront of targeted therapy innovation. In this expert-led CME activity, Dr. Christine Bestvina (USA) breaks down the latest evidence and strategies shaping treatment for KRAS-mutant NSCLC. ✅ Understand how KRAS mutations drive tumour behaviour ✅ Explore recent efficacy & safety data for KRAS-targeted therapies ✅ Gain insight into emerging treatment strategies and clinical applications Whether you’re managing patients now or preparing for future practice, this focused module delivers the knowledge you need to make confident, evidence-based decisions. 🎓 Earn CME credits while enhancing your clinical expertise. 👉 Watch now: https://touchoncologyime.org/breakthr... This activity is funded by an independent medical education grant from Revolution Medicines. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. #OncologyEducation #NSCLC #KRAS #CME #LungCancer #TargetedTherapy #HCPeducation